Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 43.90
+0.10 (0.23%)
Mar 5, 2026, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 3.81 billion as of March 5, 2026. Its market cap has decreased by -9.95% in one year.
Market Cap
3.81B
Enterprise Value
5.64B
Revenue
4.53B
Ranking
n/a
PE Ratio
n/a
Stock Price
43.90
Market Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 3.81B, an increase of 443.40%. That is a compound annual growth rate of 8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 3.80B | -2.23% |
| Dec 31, 2025 | 3.89B | -7.05% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Laboratories | 6.53B |
| SCI Pharmtech | 6.19B |
| Orient Pharma | 5.88B |
| Easywell Biomedicals | 3.52B |
| LIWANLI Innovation | 3.35B |
| Merdury Biopharmaceutical | 3.32B |
| Maywufa Company | 2.90B |
| PhytoHealth | 2.73B |